The global anesthesia monitoring devices market is poised for significant expansion, with a projected value of USD 5,722.47 million by 2031. This translates to a compelling CAGR of 12.1% during the forecast period of 2024-2031, according to a recent market analysis. The market was valued at USD 2,294.77 million in 2023. This press release explores the anesthesia monitoring devices...

The Emergency Medical Supplies Market in 2023 is US$ 21.6 billion, and is expected to reach US$ 35.54 billion by 2031 at a CAGR of 6.42%. FutureWise Research published a report that analyzes Emergency Medical Supplies Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on...

The first moments of a newborn’s life are critical, often determining long-term health outcomes. The global newborn screening market is at the forefront of safeguarding this critical phase, projected to reach $2.69 billion by 2031 with a steady CAGR of 7.8% from 2024 to 2031, according to Meticulous Research®. This growth is driven by increasing awareness of...

The newborn screening market which was USD 0.188 billion in 2022, is expected to reach USD 0.37 billion by 2030, at a CAGR of 9% during the forecast period 2023 to 2030. Market Definition Newborn screening is a type of newborn screening procedure used to rule out potentially fatal conditions such as metabolic and genetic disorders that are not visible at birth. These tests enable health care...

The global lower respiratory tract disease diagnosis and treatment market is anticipated to grow at a CAGR of 7.4% during the forecast period (2023-2030). The prevailing cause of illness and mortality in both children and adults around the globe is lower respiratory tract infections. Some of the major lower respiratory tract infections includes acute bronchitis, pneumonia, acute...

The Newborn Screening Market is experiencing significant growth, projected to reach $2.49 billion by 2030, with a compound annual growth rate (CAGR) of 7.9% from 2023 to 2030. This growth is primarily driven by several factors, including the rising prevalence of congenital heart diseases and genetic disorders, an increasing neonatal population, and heightened awareness...

New-Born Screening Market Newborn screening is the practice of testing every newborn for some harmful or possibly fatal disorders that are not otherwise obvious at birth. New-born screening involves the use of various devices for the screening procedure. Diseases such as phenylketonuria, congenital hypothyroidism, galactosemia, sickle cell disease, cystic fibrosis, tyrosinemia, and other such...

New-Born Screening Market Newborn screening is the practice of testing every newborn for some harmful or possibly fatal disorders that are not otherwise obvious at birth. New-born screening involves the use of various devices for the screening procedure. Diseases such as phenylketonuria, congenital hypothyroidism, galactosemia, sickle cell disease, cystic fibrosis, tyrosinemia, and other such...

New-Born Screening Market The Global  New-Born Screening Market Size is expected to register a CAGR of 13.33% during the forecast period with a market value of USD 1545.98 Million till 2025.  Newborn screening is the practice of testing every newborn for some harmful or possibly fatal disorders that are not otherwise obvious at birth. New-born...

New-Born Screening Market Newborn screening is the practice of testing every newborn for some harmful or possibly fatal disorders that are not otherwise obvious at birth. New-born screening involves the use of various devices for the screening procedure. Diseases such as phenylketonuria, congenital hypothyroidism, galactosemia, sickle cell disease, cystic fibrosis, tyrosinemia, and other such...